TABLE 2.
Comparison of genotypes and allele distribution frequencies between the CC group and its subgroups with the healthy control group.
| Genotype and allele | Control | Case | P | OR [95% CI] | Statistical model | P′ | P′′ | OR [95% CI] |
|---|---|---|---|---|---|---|---|---|
| Controls (n= 495) | CC(n = 482) | |||||||
| AA | 259 (52.3%) | 235 (48.8%) | Dominant | 0.2054 | 0.2095 | 0.829[0.620–1.108] | ||
| AG | 189 (38.2%) | 199 (41.3%) | Recessive | 0.5305 | 0.5327 | 0.852[0.516–1.406] | ||
| GG | 47 (9.49%) | 48 (9.96%) | 0.5322 | Additive | 0.2132 | 0.2088 | 0.868[0.696–1.084] | |
| A | 707 (71.4%) | 669 (69.4%) | ||||||
| G | 283 (28.6%) | 295 (30.6%) | 0.3290 | 0.908[0.747–1.102] | ||||
| Controls (n= 495) | SCC (n = 416) | |||||||
| AA | 259 (52.3%) | 204 (49.0%) | Dominant | 0.2967 | 0.2968 | 0.851[0.628–1.152] | ||
| AG | 189 (38.2%) | 169 (40.6%) | Recessive | 0.4040 | 0.4110 | 0.801[0.476–1.348] | ||
| GG | 47 (9.49%) | 43 (10.3%) | 0.6110 | Additive | 0.2443 | 0.2437 | 0.872[0.692–1.098] | |
| A | 707 (71.4%) | 577 (69.4%) | ||||||
| G | 283 (28.6%) | 255 (30.6%) | 0.3362 | 1.104[0.902–1.351] | ||||
| Controls (n= 495) | AUC(n = 36) | |||||||
| AA | 259 (52.3%) | 16 (44.4%) | Dominant | 0.2542 | 0.2631 | 0.659[0.321–1.350] | ||
| AG | 189 (38.2%) | 16 (44.4%) | Recessive | 0.5203 | 0.5204 | 0.680[0.209–2.207] | ||
| GG | 47 (9.49%) | 4 (11.1%) | 0.6589 | Additive | 0.2441 | 0.2462 | 0.727[0.425–1.243] | |
| A | 707 (71.4%) | 48 (66.7%) | ||||||
| G | 283 (28.6%) | 24 (33.3%) | 0.3909 | 0.801[0.481–1.332] |
CC, cervical cancer; SCC, squamous carcinoma of cervical; AUC, adenocarcinoma of the uterine cervical; OR, odds ratio; CI, confidence interval.
P: p-value (control vs. CC; control vs. SCC; control vs. AUC ); p-values <0.05 are shown in bold.
P’: age was adjusted.
P”: the p-value was calculated using 10,000 permutations for each model to correct the multiple tests.